Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000083

Chief Business Officer gave up 661 shares (to pay taxes)

  • Chief Business Officer acquired 2,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Boyle Scott N · Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-16 Exercise or conversion : show line 1 in the form +2,250 54,580 D
2024-09-16 Shares withheld for taxes : show line 2 in the form −661 $6.36 $4,204 53,919 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-09-16 Exercise or conversion : show line 3 in the form Performance Restricted Stock Units −2,250 14,250 D
Loading xslF345X05/wk-form4_1726607550.xml…